used in standard Chinese, Ayurvedic, and Thai drugs. Conolidine could represent the start of a different period of Long-term pain administration. It is currently getting investigated for its outcomes to the atypical chemokine receptor (ACK3). In a rat design, it was located that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3